FFM
MDT icon

Fullerton Fund Management’s Medtronic MDT Stock Holding History

Fullerton Fund Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,641
Closed -$230K – 162
2024
Q1 		$230K Buy
+2,641
New +$225K 0.01% 158
2021
Q1 		– Sell
-4,273
Closed -$501K – 82
2020
Q4 		$501K Buy
4,273
+2,520
+144% +$277K 0.04% 70
2020
Q3 		$182K Buy
+1,753
New +$176K 0.02% 65

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fullerton Fund Management's MDT Position: Q2 2024 in Review

Fullerton Fund Management sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,641 shares — an estimated $230K sold.

Fullerton Fund Management first reported a position in MDT in Q3 2020 and held it in 3 quarters. The position peaked at $501K in Q4 2020. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Fullerton Fund Management reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Fullerton Fund Management sold 2,641 Medtronic shares in Q2 2024, an estimated $230K.
  • Fullerton Fund Management first reported a position in Medtronic in Q3 2020 and held it in 3 quarters.
  • Fullerton Fund Management's Medtronic position peaked at $501K in Q4 2020.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Fullerton Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.